Publicado 4 números por año
ISSN Imprimir: 0731-8898
ISSN En Línea: 2162-6537
Indexed in
CD10 and E-Cad Expression in Urinary Bladder Urothelial and Squamous Cell Carcinoma
SINOPSIS
Identification of prognostic markers in bladder carcinoma comprises a major clinical issue and therapeutic target. CD10 and the adhesion molecule E-cadherin (E-cad) are expressed in a variety of normal tissues and their neoplasms. CD10 is able to degrade extracellular matrix and other proteins, including adhesion molecules. The roles of CD10 and E-cad and their relationship in the development and progression of bladder carcinoma are poorly understood. The aim of this study was to investigate the expression of CD10 and E-cad in bladder carcinomas and relate the results to the established prognostic factors. This study included 144 patients with bladder carcinoma, including 72 with transitional cell carcinoma (TCC; 30 bilharzial and 42 nonbilharzial) and 72 with squamous cell carcinoma (SCC; 38 bilharzial and 34 nonbilharzial). Immunohistochemical analysis for both CD10 and E-cad were carried out on paraffin-fixed sections of neoplastic bladder tissues. CD10 tumor cells, CD10 stromal cells, and E-cad were expressed in 56%, 58%, and 51% of cancer bladder cases, respectively. There was a statistically significant correlation between percentage of tumor cells positively stained by CD10 and each of the tumor grade, clinical stage, and lymph node metastasis of both TCC and SCC. There was a significant statistical correlation between immunostaining by E-cad marker and each of the tumor grade, clinical stage, and lymph node metastasis of TCC, but no such association with SCC. The frequency of stromal expression of CD10 was higher in bilharzial-associated bladder carcinomas than in nonbilharzial ones, and these results were statistically significant. In conclusion, increased expression of CD10 in the tumor and stromal cells of both TCC and SCC and decreased expression of E-cad in the tumor cells of only TCC are strongly correlated with tumor progression, invasion, and metastasis in human bladder cancer.
-
Ahmed Ahmed R.H., Muhammad Eman M.S., E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions, Journal of the Egyptian National Cancer Institute, 26, 4, 2014. Crossref
-
Hussain Maha, Daignault Stephanie, Agarwal Neeraj, Grivas Petros D., Siefker-Radtke Arlene O., Puzanov Igor, MacVicar Gary R., Levine Ellis Glenn, Srinivas Sandy, Twardowski Przemyslaw, Eisenberger Mario A., Quinn David I., Vaishampayan Ulka N., Yu Evan Y., Dawsey Scott, Day Kathleen C., Day Mark L., Al-Hawary Mahmoud, Smith David C., A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma, Cancer, 120, 17, 2014. Crossref
-
Wong Thian-Sze, Gao Wei, Chan Jimmy Yu-Wai, Transcription Regulation of E-Cadherin by Zinc Finger E-Box Binding Homeobox Proteins in Solid Tumors, BioMed Research International, 2014, 2014. Crossref
-
Ghafouri-Fard Soudeh, Nekoohesh Leili, Motevaseli Elahe, Bladder Cancer Biomarkers: Review and Update, Asian Pacific Journal of Cancer Prevention, 15, 6, 2014. Crossref
-
Tian Wei, Epstein Jonathan I., Invasive low-grade papillary urothelial carcinoma: an immunohistochemical study of 26 cases, Human Pathology, 46, 12, 2015. Crossref
-
Stephen H M, Khoury R J, Majmudar P R, Blaylock T, Hawkins K, Salama M S, Scott M D, Cosminsky B, Utreja N K, Britt J, Conway R E, Epigenetic suppression of neprilysin regulates breast cancer invasion, Oncogenesis, 5, 3, 2016. Crossref
-
Stivarou Theodora, Patsavoudi Evangelia, Extracellular Molecules Involved in Cancer Cell Invasion, Cancers, 7, 1, 2015. Crossref
-
Oba Junna, Nakahara Takeshi, Hashimoto-Hachiya Akiko, Liu Min, Abe Takeru, Hagihara Akihito, Yokomizo Takehiko, Furue Masutaka, Dadras Soheil S., CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis, PLOS ONE, 11, 2, 2016. Crossref
-
Apollo Alessandro, Ortenzi Valerio, Scatena Cristian, Zavaglia Katia, Aretini Paolo, Lessi Francesca, Franceschi Sara, Tomei Sara, Sepich Carlo Alberto, Viacava Paolo, Mazzanti Chiara Maria, Naccarato Antonio Giuseppe, Real Francisco X., Molecular characterization of low grade and high grade bladder cancer, PLOS ONE, 14, 1, 2019. Crossref
-
Maia Manuel Caitano, Hansen Aaron, Alves Carolina, Salah Samer, Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review, Critical Reviews in Oncology/Hematology, 135, 2019. Crossref
-
Shukla SushilKumar, Chandra Smita, Chauhan Neena, Sarpal Rajeev, Expression of CD10 in urothelial carcinoma of the bladder and its correlation with histopathological grade, pathological stage, and survival of patients, Journal of Cancer Research and Therapeutics, 17, 4, 2021. Crossref